March 2026 in “JPRAS Open” This source reviews the potential of exosome-based therapies for various types of hair loss, highlighting promising preclinical mechanisms and signaling pathways such as Wnt/β-catenin, PI3K/AKT, VEGF, and TGF-β involved in the regenerative properties of extracellular vesicles.
October 2025 in “International Journal of Innovative Research in Technology” This review examines the evidence on nutritional and herbal supplements for women's health, emphasizing the need for more long-term studies to develop evidence-based guidelines for personalized supplementation.
3 citations
,
May 2013 in “Journal of the American Association of Nurse Practitioners” This review evaluates six primary studies on androgenetic alopecia treatments and suggests topical minoxidil or finasteride as first-line options, recommending further research into treatments and practice guidelines.
5 citations
,
April 2025 in “Journal of Cosmetic Dermatology” This study evaluated eight JAK inhibitor regimens for alopecia areata and provided high-quality evidence on their comparative effectiveness, which can aid clinicians in decision-making and inform medical practice guidelines.
117 citations
,
February 2017 in “American Journal of Clinical Dermatology” This systematic review concluded that the support for using spironolactone at commonly prescribed doses is based on evidence of limited quality.
Hair restoration is advancing with new treatments and needs collaboration across fields for effective, evidence-based care.
This article reviews management strategies for nonscarring and scarring alopecias, noting insufficient evidence-based guidelines for scarring types due to their rarity.
43 citations
,
June 2016 in “Clinics in Plastic Surgery” This article reviews technical aspects of using autologous fat transfer for facial rejuvenation and examines existing evidence for stem cell and platelet-rich plasma therapies in aesthetic practice, reporting no new results.
76 citations
,
May 2020 in “Ultraschall in der Medizin - European Journal of Ultrasound” This consensus document provides foundational position statements for dermatologic ultrasound but reports no clinical results; it aims to guide future evidence-based recommendations and guidelines.
July 2011 in “Hair transplant forum international” This article discusses the potential of green tea to treat iron overload by reducing iron absorption, based on a clinical case from the author's practice, and reports no new findings.
10 citations
,
February 2010 in “Journal of Dermatological Treatment” This review discusses the history, strengths, and weaknesses of dermatology podcasts and provides no new results, advocating for more involvement from prestigious journals and institutions in creating evidence-based content.
December 2023 in “International Journal of Research in Ayurveda and Pharmacy” This review examines Ayurvedic herbs and formulations described in ancient texts for cancer treatment, noting a lack of evidence-based research on their efficacy and potential use in oncology.
August 2026 in “Pharmacological Research - Modern Chinese Medicine” This review reports that microneedle systems can enhance the delivery and effectiveness of Traditional Chinese Medicine compounds in treating skin disorders, though most findings are based on preclinical studies and face challenges in translating to clinical practice.
October 2025 in “International Journal For Multidisciplinary Research” This review study found strong scientific support for traditional Indian hair care practices, demonstrating that herbs like Amla, Bhringraj, and Ashwagandha have beneficial effects on hair growth and scalp health, backed by technological advancements that enhance their therapeutic potential.
June 2022 in “Veterinary evidence” This study reported no evidence that clomipramine reduces overgrooming or improves hair regrowth in cats with psychogenic alopecia compared to untreated cats.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, Jeffi Chao Hui Wu documented physiological transformations from his "Danben Origin" practice, including the natural reversal of conditions like androgenetic alopecia, macular degeneration, and carpal tunnel syndrome.
Managing telogen effluvium is challenging due to limited scientific evidence.
86 citations
,
January 2021 in “Gland Surgery” This review article found no concrete evidence supporting the existence of "silicone implant illness" as a new syndrome, despite the association of various symptoms with breast implants which are considered safe according to current evidence.
2 citations
,
March 2020 in “Plastic and Reconstructive Surgery” This review discusses platelet-rich plasma and microneedling in aesthetic medicine, providing a comprehensive literature summary and practical insights, but reports no new clinical results.
February 2026 in “Plastic and Aesthetic Research” This narrative review examines advancements in regenerative aesthetic medicine, focusing on injectable modalities like PRP, polynucleotides, and exosomes, but highlights the need for more robust evidence and standardization in clinical applications.
Surgeons should evaluate new technologies critically, offer a range of services including non-surgical options, and be aware of marketing influences to meet patient needs and maintain a successful practice.
4 citations
,
August 2021 in “Clinical and Experimental Reproductive Medicine” This review highlights key clinical recommendations from the 2018 international guidelines on PCOS management and questions if these guidelines will be widely adopted in practice.
November 2025 in “World Journal of Biology Pharmacy and Health Sciences” This review reported that premature greying in children, which can indicate certain deficiencies or disorders, may be addressed through a structured evaluation and treatment targeting factors like vitamin B12 and iron deficiencies or hypothyroidism, providing a practical approach for pediatric care.
10 citations
,
January 2023 in “Annals of Dermatology” This study produced updated treatment guidelines for severe alopecia areata patients in Korea, highlighting the efficacy of systemic corticosteroids, oral cyclosporine, and Janus kinase inhibitors.
1 citations
,
January 2025 in “Updates in clinical dermatology” New treatments for vitiligo, including the first FDA-approved option, are improving patient care and quality of life.
3 citations
,
November 2009 in “BMC dermatology” This study found that dermatologists in the southeastern U.S. often offer less frequent treatment for children with alopecia areata compared to adults, with more treatment also recommended for more advanced stages of hair loss.
30 citations
,
July 2004 in “Fertility and Sterility” Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
November 2025 in “British Journal of Dermatology” This guideline by the British Association of Dermatologists reviews managing alopecia areata and provides 56 recommendations but reports no new clinical results.
This study found that dermatologists in the southeastern United States are inconsistent in treating alopecia areata, often recommending no treatment, especially for children and more advanced hair loss stages.
February 2014 in “PubMed” This review reports that treatment recommendations for cicatricial alopecia remain challenging due to its rarity, unclear etiology, lack of a definitive therapy, and limited drug availability in Italy, while established regimens exist for other types of alopecia.